Lo S - Search Results

1

Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites.

Conway JW, Rawson RV, Lo S, Ahmed T, Vergara IA, Gide TN, Attrill GH, Carlino MS, Saw RPM, Thompson JF, Spillane AJ, Shannon KF, Shivalingam B, Menzies AM, Wilmott JS, Long GV, Scolyer RA, Pires da Silva I. Conway JW, et al. Among authors: lo s. J Immunother Cancer. 2022 Sep;10(9):e004884. doi: 10.1136/jitc-2022-004884. J Immunother Cancer. 2022. PMID: 36096531 Free PMC article.

2

Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors.

Menzies AM, Wilmott JS, Drummond M, Lo S, Lyle M, Chan MM, Thompson JF, Guminski A, Carlino MS, Scolyer RA, Kefford RF, Long GV. Menzies AM, et al. Among authors: lo s. Cancer. 2015 Nov 1;121(21):3826-35. doi: 10.1002/cncr.29586. Epub 2015 Jul 28. Cancer. 2015. PMID: 26218930 Free article.

3

Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient Management.

Ge L, Vilain RE, Lo S, Aivazian K, Scolyer RA, Thompson JF. Ge L, et al. Among authors: lo s. Ann Surg Oncol. 2016 Aug;23(8):2658-63. doi: 10.1245/s10434-016-5196-1. Epub 2016 Apr 13. Ann Surg Oncol. 2016. PMID: 27075324

4

Debate: adjuvant whole brain radiotherapy or not? More data is the wiser choice.

Fogarty GB, Hong A, Gondi V, Burmeister B, Jacobsen K, Lo S, Paton E, Shivalingam B, Thompson JF. Fogarty GB, et al. Among authors: lo s. BMC Cancer. 2016 Jul 1;16:372. doi: 10.1186/s12885-016-2433-8. BMC Cancer. 2016. PMID: 27370683 Free PMC article.

5

Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.

Rawson RV, Johansson PA, Hayward NK, Waddell N, Patch AM, Lo S, Pearson JV, Thompson JF, Mann GJ, Scolyer RA, Wilmott JS. Rawson RV, et al. Among authors: lo s. Lab Invest. 2017 Feb;97(2):130-145. doi: 10.1038/labinvest.2016.143. Epub 2017 Jan 9. Lab Invest. 2017. PMID: 28067894 Free article.

6

Extranodal Spread is Associated with Recurrence and Poor Survival in Stage III Cutaneous Melanoma Patients.

Crookes TR, Scolyer RA, Lo S, Drummond M, Spillane AJ. Crookes TR, et al. Among authors: lo s. Ann Surg Oncol. 2017 May;24(5):1378-1385. doi: 10.1245/s10434-016-5723-0. Epub 2017 Jan 27. Ann Surg Oncol. 2017. PMID: 28130620

7

A multireferral centre retrospective cohort analysis on the experience in treatment of metastatic uveal melanoma and utilization of sequential liver-directed treatment and immunotherapy.

Itchins M, Ascierto PA, Menzies AM, Oatley M, Lo S, Douraghi-Zadeh D, Harrington T, Maher R, Grimaldi AM, Guminski A. Itchins M, et al. Among authors: lo s. Melanoma Res. 2017 Jun;27(3):243-250. doi: 10.1097/CMR.0000000000000343. Melanoma Res. 2017. PMID: 28230715

8

Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies.

Choong ES, Lo S, Drummond M, Fogarty GB, Menzies AM, Guminski A, Shivalingam B, Clarke K, Long GV, Hong AM. Choong ES, et al. Among authors: lo s. Eur J Cancer. 2017 Apr;75:169-178. doi: 10.1016/j.ejca.2017.01.007. Epub 2017 Feb 23. Eur J Cancer. 2017. PMID: 28236768

9

Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma Metastasis.

Haydu LE, Scolyer RA, Lo S, Quinn MJ, Saw RPM, Shannon KF, Spillane AJ, Stretch JR, McCarthy WH, Thompson JF. Haydu LE, et al. Among authors: lo s. J Clin Oncol. 2017 May 20;35(15):1721-1729. doi: 10.1200/JCO.2016.71.9393. Epub 2017 Apr 4. J Clin Oncol. 2017. PMID: 28375785

10

Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma.

Vilain RE, Menzies AM, Wilmott JS, Kakavand H, Madore J, Guminski A, Liniker E, Kong BY, Cooper AJ, Howle JR, Saw RPM, Jakrot V, Lo S, Thompson JF, Carlino MS, Kefford RF, Long GV, Scolyer RA. Vilain RE, et al. Among authors: lo s. Clin Cancer Res. 2017 Sep 1;23(17):5024-5033. doi: 10.1158/1078-0432.CCR-16-0698. Epub 2017 May 16. Clin Cancer Res. 2017. PMID: 28512174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,672 results

Search Page